Abu Dhabi's Department Of Health Offers Early Access To WINREVAIR For Pulmonary Arterial Hypertension Patients

The Department of Health – Abu Dhabi (DoH) has introduced a new medication for Pulmonary Arterial Hypertension, making Abu Dhabi the first in the region to offer it. This development is a major step in improving healthcare outcomes for patients with this condition. WINREVAIR, administered via subcutaneous injection every three weeks, can be self-administered under medical supervision.

WINREVAIR targets specific signalling pathways that cause excessive cell growth in pulmonary blood vessels. This action helps reduce vascular narrowing, improving blood flow and easing cardiovascular strain. Used alongside standard treatments, it lowers mortality risks in low to moderate-risk patients. The first batch of WINREVAIR arrived this month, marking a significant milestone.

Clinical studies have shown that adding WINREVAIR to standard treatments can reduce fatal and non-fatal clinical worsening events by 84 percent. It also enhances exercise capacity and decreases pulmonary vascular resistance. These improvements suggest a potential increase in life expectancy by over ten years when combined with current therapies.

WINREVAIR has received approval from both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Developed by MSD, a leading biopharmaceutical company, its introduction is expected to significantly impact patient care. Global statistics show Pulmonary Arterial Hypertension affects 15 to 60 people per million, with women making up 70 to 80 percent of cases.

The condition is most common among those aged 50 to 65. The availability of WINREVAIR offers hope for improved management of this challenging condition. By addressing key pathways involved in disease progression, it provides an effective option for enhancing patient quality of life and extending survival rates.

This advancement underscores Abu Dhabi's commitment to pioneering healthcare solutions and improving patient outcomes across the region.

With inputs from WAM